GTG at the moment appears to have minimal downside risk. By that I mean a complete re-rating downwards, not the day to day fluctuations. The license contracts should have put some sort of safety net under this stock. Impossible as it is for me to put a value on GTG at the moment the only downside risk I see would be a sudden halt in the licenses being granted. And that ain't gunna happen!
So, the risk / reward looks pretty attractive.
However, anything can and does happen!
Is there a better BioTech at the moment? I don't think there is.
Go you little ripper!!!!!!!!!!!!!
The downside risk
Add GTG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $36.56M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $43.19K | 4.338M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 16311346 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 2749165 | 6 |
View Market Depth
| Last trade - 16.10pm 17/01/2020 (20 minute delay) ? |
 (live)
|
|||||
|
Last
1.0¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.9¢ | 1.0¢ | 0.9¢ | 532444 | ||
| Last updated 15.23pm 17/01/2020 (live) ? | |||||
| GTG (ASX) Chart |